glp-1 cardiovascular outcomes news medications are not just for weight loss โ they are the most important drug class of our lifetime. ๐ซ A 2025 meta-analysis of 99,599 patients confirmed: โ 20% reduction in major Cardiovascular, Kidney, and Safety Outcomes
Description
See if you qualify Are you a candidate for medical weight loss
Importantly, GLP-1 receptors are found not only in neurons but also in glial cells, which mediate its effects on brain health by regulating energy balance and maintaining neural circuits
they seek insights that help them make better decisions
February 2025 A study published January 30, 2025, found that medications like Ozempic, commonly used to treat diabetes and aid in weight loss, may be linked to rare eye conditions that can cause vision loss or even blindness
clinicaltrials.gov/study/NCT0381156
203 MilaniCDurantiSBottaciniFCaseyETurroniFMahonyJet al
